{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-030190","form_type":"8-K","ticker":"SRXH","cik":"0001471727","company_name":"SRx Health Solutions, Inc.","filed_at":"2023-08-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.018254+00:00","generated_at":"2026-06-11T05:33:09.704144+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Better Choice Q2 net revenue $10.5M; gross margin up 543 bps YoY to 34%","bullets":["Net revenue of $10.5M, down 36% YoY but up 14% from Q1 2023.","Gross margin improved 543 bps YoY to 34%; operating loss improved 39% to $(2.6)M.","Net loss improved 32% to $(3.0)M; EPS improved 33% YoY to $(0.10).","Appointed Kent Cunningham as CEO; strategic partnership with Alphia for dry kibble manufacturing.","Paid down $13.5M revolving credit line; supply chain constraints expected to resolve by end of Q3."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-030190","json":"https://secwatch.observer/filing/0001628280-23-030190.json","markdown":"https://secwatch.observer/filing/0001628280-23-030190.md","text":"https://secwatch.observer/filing/0001628280-23-030190.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1471727/000162828023030190/0001628280-23-030190-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1471727/000162828023030190/bttr-20230821.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T05:33:09.704144+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9f9059850af7a79ab496a50e402ae96778b38274","claim":"SRx Health Solutions, Inc. reported second quarter ended June 30, 2023 results: revenue $10.5 million, net income $(3.0) million, EPS $(0.10).","evidence_excerpt":"Net revenue increased 14% from first quarter 2023 to $10.5 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1471727/000162828023030190/0001628280-23-030190-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Revenue","value":"$10.5 million"},{"label":"Net income","value":"$(3.0) million"},{"label":"EPS","value":"$(0.10)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}